stitcherLogoCreated with Sketch.
Get Premium Download App
Listen
Discover
Premium
Shows
Likes
Merch

Listen Now

Discover Premium Shows Likes

BioBoss

65 Episodes

44 minutes | May 27, 2023
#60 - Naseem Amin: CEO of Orphalan
Naseem Amin,  CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
50 minutes | Apr 22, 2023
#59 - Hartmut Ehrlich: CEO of Abivax
Hartmut Ehrlich,  CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
42 minutes | Apr 1, 2023
#58 - Ivo Timmermans: co-founder & CEO, Pleco Therapeutics
Ivo Timmermans, co-founder and  CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.
39 minutes | Mar 4, 2023
#57 - Philipp Spycher: Co-founder & CEO, Araris Biotech
Philipp Spycher, co-founder and  CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug conjugates that enables attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
39 minutes | Feb 4, 2023
#56 - Patrick Arensdorf: Founder & CEO, Exai Bio
Pat Arensdorf, founder and  CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.
34 minutes | Jan 1, 2023
#55 - Josh Geballe: Managing Director of Yale Ventures
Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.
1 minutes | Dec 31, 2022
Welcome to Season 5 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 5.John is delighted to open BioBoss season 5 with his conversation with Josh Geballe, Managing Director of Yale Ventures, who shares his thoughts about leadership, innovation, entrepreneurship and community building in biopharma and biotech. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.
42 minutes | Dec 3, 2022
#54 - Luca Benatti: CEO, EryDel
Luca Benatti,  CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the patient’s own blood.
35 minutes | Oct 29, 2022
#53 - Elisabet de los Pinos: Founder/CEO, Aura Biosciences
Elisabet de los Pinos, founder and CEO of Aura Biosciences, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Aura is working to envision new ways to treat cancer.
46 minutes | Oct 8, 2022
#52 - Paul Radspinner: Founder & CEO, Flugen
Paul Radspinner, founder and CEO of Flugen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Flugen is working to develop a more effective vaccine in the fight against influenza and respiratory disease.
42 minutes | Sep 19, 2022
#51 - Jesús Martin-Garcia: CEO of GeNeuro
Jesús Martin-Garcia, CEO of GeNeuro, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Geneuro is working to develop treatments against neurological disorders and autoimmune diseases by neutralizing causal factors encoded by Human Endogenous Retroviruses.
34 minutes | Aug 17, 2022
#50 - Cliff Stocks: Founder and CEO, OncoResponse
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
41 minutes | Jul 16, 2022
#49 - Brian Finrow: Co-founder & CEO, Lumen Bioscience
Brian Finrow, Co-founder and CEO of Lumen Bioscience, speaks with BioBoss host and biopharma branding veteran John Simboli. Hear Brian’s thoughts about leadership and how Lumen Biosciences is working to unlock the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. 
37 minutes | Jun 18, 2022
#48 - Alex Blyth: Founder & CEO, LifT BioSciences
30 minutes | May 21, 2022
#47 - Andrew Hall: CEO of IMV Inc.
40 minutes | Apr 18, 2022
#46 - Kevin Lee: CEO of Bicycle Biotherapeutics
Kevin Lee, CEO of Bicycle Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Bicycle Therapeutics is working on developing a new class of medicines, called Bicycles, for diseases that are underserved by existing therapeutics. 
27 minutes | Mar 26, 2022
#45 - Reenie McCarthy: CEO of Stealth BioTherapeutics
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeutics is working on developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
41 minutes | Feb 5, 2022
#44 - Yochi Slonim: Founder & CEO, Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima Biotech is working on a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins.
33 minutes | Jan 8, 2022
#43 - Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics  is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene  pathways
1 minutes | Dec 28, 2021
Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in  BioBoss season 4.
COMPANY
About us Careers Stitcher Blog Help
AFFILIATES
Partner Portal Advertisers Podswag Stitcher Studios
Privacy Policy Terms of Service Your Privacy Choices
© Stitcher 2023